Patterning in Birthweight in India: Analysis of Maternal Recall and Health Card Data by Malavika A. Subramanyam (104709)

“…Children were less likely to be born with low birthweight if they had mothers with over 12 years of education compared to 1–5 years of education with relative risk (RR) of 0.79 (95% confidence interval [CI]: 0.52, 1.2) in the card sample and 0.70 (95% CI: 0.59, 0.84) in the recall sample. A 100 gram difference in a child's birthweight was associated with a decreased likelihood of underweight in both the card (RR: 0.95; 95% CI: 0.94, 0.96) and recall (RR: 0.96; 95% CI: 0.96, 0.97) samples.…”

miR-223 null macrophages have enhanced inflammatory signaling and increased FBXW7 levels. by Jeffrey A. Deiuliis (3331071)

“…<p>(A) Effect of LPS (100ng/ml) on mmu-miR-223 levels in the mouse macrophage cell line Raw264.7 and in primary mouse macrophages from C57BL/6J mice as measured by qPCR, relative to snoRNA234. …”

High Q/N content of Sup35 antagonizes degradation. by Sean M. Cascarina (525186)

“…Partial substitution of G residues for Q/N residues within the A2 PrLD resulted in an <i>ade</i>^<i>-</i> phenotype (<i>left</i>), and corresponding decrease in degradation rate (<i>right</i>). …”

Model Studies of 6,7-Indolequinone Cofactors of Quinoprotein Amine Dehydrogenases by Yoko Murakami (423119)

“…The reactivity of indolequinones <b>2</b> and <b>3</b> is further decreased due to their stronger electron-donating substituents at C-4. …”

Measured time series from e-Rep circuit showing the period-1 LC (protein <i>A</i>-yellow, <i>B</i>-blue and <i>C</i>-purple). by Edward H. Hellen (346773)

“…<p>β = 0.1, α = 46, n = 3, <i>k</i>_S1 = 0.025, <i>k</i>_S0 = 1, and η = 1. (a) κ = 14, (b) κ = 19. Note that the protein oscillation amplitudes are larger in frame (a) than (b) since the vertical scale is 200 mV/div in (a) and 100 mV/div in (b). …”

The 2.1 Å Resolution Structure of Cyanopindolol-Bound β₁-Adrenoceptor Identifies an Intramembrane Na⁺ Ion that Stabilises the Ligand-Free Receptor by Jennifer L. Miller-Gallacher (541986)

“…We have determined the structure of an ultra-thermostable β₁AR mutant bound to the weak partial agonist cyanopindolol to 2.1 Å resolution. High-quality crystals (100 μm plates) were grown in lipidic cubic phase without the assistance of a T4 lysozyme or BRIL fusion in cytoplasmic loop 3, which is commonly employed for GPCR crystallisation. …”

IAA application on <i>pin1</i> meristem leads to local tissue softening and pectin de-methyl-esterification in sub-epidermal tissues. by Siobhan A. Braybrook (388465)

“…Note that meristem curvature does not correlate with areas of decreased E_A, and that there is no bulging of the meristem accompanying decreased rigidity. …”

Table1_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Image1_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Image2_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Image1_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Table1_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Image2_Tang Luo Ning, a Traditional Chinese Compound Prescription, Ameliorates Schwannopathy of Diabetic Peripheral Neuropathy Rats by Regulating Mitochondrial Dynamics In Vivo and... by Jiayue Zhu (10800972)

“…Our results showed that TLN increased ATP levels (0.38 of model, 0.69 of HTLN, 0.61 of LTLN, P＜0.01; 0.52 of 150 mM glucose, 1.00 of 10% TLN, P＜0.01, 0.94 of 1% TLN, P＜0.05), MMP (0.56 of 150 mM glucose, P＜0.01, 0.75 of 10% TLN, P＜0.05, 0.83 of 1% TLN, P＜0.01), and mtDNA (0.32 of 150 mM glucose, 0.43 of 10% TLN, P＜0.01) while decreased Ca²⁺ (1.54 of model, 1.06 of HTLN, 0.96 of LTLN, P＜0.01) to improve mitochondrial function in vivo and in vitro. …”

Fig 7 - by Caspar A. S. Pouw (9579630)

“…This ratio, which we further scale to its value at week 18, displays a ≈100% growth between week 18 and 26, to confirm that the increment of passengers contributes only for 150% of the overall exposure time growth.…”

Data_Sheet_1_Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions.docx by Mohamed A. Abdelnaim (16976001)

“…Out of our 10 patients, 6 have shown a clear response indicated by a YBOCS-reduction between 42 and 100 percent at last follow-up. …”

Expression of emGFP-Igf2bp1^Y399E in RGCs disrupts axon outgrowth <i>in vivo</i>. by John A. Gaynes (790924)

“…<p>(a-c) Dorsal confocal projections (30x silicone immersion lens) of Tg(<i>isl2b</i>:emGFP) (a), Tg(<i>isl2b</i>:emGFP-Igf2bp1)^wt (b), and Tg(<i>isl2b</i>:emGFP-Igf2bp1)^Y399E (c) 3 dpf transient transgenic embryos. …”

Data_Sheet_1_Examining Genetic Variation in Maize Inbreds and Mapping Oxidative Stress Response QTL in B73-Mo17 Nearly Isogenic Lines.docx by Crystal A. Sorgini (6915314)

“…In Mo17 NILs, a significant leaf damage QTL was identified at 161Mb on chromosome 2. …”

Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory... by Shaymaa A. Abdulmalek (4025555)

“…Experimental animals either treated with mono-therapeutic-two doses Se-NPs (0.1 and 0.4 mg/kg) and/or MET (100 mg/kg) alone as well as the combined therapy resulted in a remarkable protective anti-diabetic effect illustrated by significant decreases in fasting blood glucose and insulin levels after 8 weeks treatment. …”

Data_Sheet_1_Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts.docx by Benjamin A. T. Rodriguez (9107027)

“…<p>Type 2 diabetes is a major risk factor for cardiovascular disease. …”

EBs and neural rosettes derived from CUL9 KD clones display abnormalities. by Natalya A. Ortolano (10291721)

“…<p>(<b>A</b>) CUL9 KO cells express significantly decreased levels of CUL9 protein. …”